Resistance to piperaquine phosphate in Hainan islanders with pernicious malaria
Wu, Z.
Zhonghua Yi Xue Za Zhi 65(8): 483-484
1985
ISSN/ISBN: 0376-2491 PMID: 3931880 Document Number: 246555
Document emailed within 1 workday
Related Documents
Rijken, M.J.; McGready, R.; Boel, M.E.; Barends, M.; Proux, S.; Pimanpanarak, M.; Singhasivanon, P.; Nosten, Fçois. 2008: Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report American Journal of Tropical Medicine and Hygiene 78(4): 543-545Katrak, S.; Gasasira, A.; Arinaitwe, E.; Kakuru, A.; Wanzira, H.; Bigira, V.; Sandison, T.G.; Homsy, J.; Tappero, J.W.; Kamya, M.R.; Dorsey, G. 2009: Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children Malaria Journal 8: 272
Du, C.S.; Liu, L.B.; Liu, B.; Tokunaga, K.; Omoto, K. 1988: Glucose-6-phosphate dehydrogenase deficiency among three national minorities in Hainan Island, China Gene Geography: a Computerized Bulletin on Human Gene Frequencies 2(2-3): 71-74
Krudsood, S.; Tangpukdee, N.; Thanchatwet, V.; Wilairatana, P.; Srivilairit, S.; Pothipak, N.; Jianping, S.; Guoqiao, L.; Brittenham, G.M.; Looareesuwan, S. 2007: Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria Southeast Asian Journal of Tropical Medicine and Public Health 38(6): 971-978
Wen, L.; Xu, D.-z.; Wang, S.-q.; Li, C.-x.; Zhang, Z.-y.; Su, Y.-q. 2005: Analysis on the relationship between malaria epidemics and NOAA-AVHRR NDVi in Hainan province Zhonghua Liu Xing Bing Xue Za Zhi 26(4): 263-267
Coulaud, J.P.; Vachon, F.; Gibert, C.; Vernant, D. 1977: Present-day problems of malaria. the pernicious syndrome La Revue du Praticien 27(37): 2375-2380
Hill, K.; Ward, P.; Grace, B.S.; Gleadle, J. 2017: Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand Bmc Public Health 17(1): 802
Bastien, P. 1987: Epidemiological peculiarities of pernicious attacks by Plasmodium falciparum in the context of a malaria epidemic. Vanuatu, 1975-1985 Medecine tropicale: revue du Corps de sante colonial 47(2): 125-131
Chen, N.; Gao, Q.; Wang, S.; Wang, G.; Gatton, M.; Cheng, Q. 2008: No genetic bottleneck in Plasmodium falciparum wild-type Pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance Antimicrobial Agents and ChemoTherapy 52(1): 345-347
Coetzee, M.; van Wyk, P.; Booman, M.; Koekemoer, L.L.; Hunt, R.H. 2006: Insecticide resistance in malaria vector mosquitoes in a gold mining town in Ghana and implications for malaria control Bulletin de la Societe de Pathologie Exotique 99(5): 400-403
Rabinovich, S.A. 1976: Drug resistance in malaria parasites. 1. The nature of resistance, its distribution and epidemiological implications (review of the literature) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(4): 464-477
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Matsuoka, H.; Ishii, A.; Panjaitan, W.; Sudiranto, R. 1986: Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia Southeast Asian Journal of Tropical Medicine and Public Health 17(4): 530-536
Chadee, D.D.; Tilluckdharry, C.C.; Doon, R. 1996: Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency West Indian Medical Journal 45(3): 97-99
Mårtensson, A. 1997: Chloroquine phosphate dosage in malaria prophylaxis should be based on body weight! Lakartidningen 94(3): 114
Mbacham, W.; Njikam, N. 2007: Marqueurs moléculaires de résistance aux médicaments antipaludiques : Nécessaires mais pas suffisants pour un changement de politique de santé - Molecular markers for malaria drug resistance : Necessary but not sufficient criteria to decide change in treatment policy Medecine Tropicale 67(2): 183-187
Mathews, S.T.; Kumaresan, P.R.; Selvam, R. 1991: Glucose-6-phosphate dehydrogenase deficiency and malaria--a study on north Madras population Journal of Communicable Diseases 23(3): 178-181
1981: The pharmacological and clinical research of a new drug, pyracoine phosphate, for rescuing fulminant cerebral malaria Zhonghua Nei Ke Za Zhi 20(3): 180-181
Shao, B.R.; Ye, X.Y. 1986: Delay in emergence of resistance to pyronaridine phosphate in Plasmodium berghei Zhongguo Yao Li Xue Bao 7(5): 463-467
Nie, C.; Zhao, S. 1999: A diagnostic kit to screen individuals with glucose-6-phosphate dehydrogenase defect and its application on anti-malaria spot in the countryside Chinese Medical Journal 112(4): 349-351